Press release
Age Related Macular Degeneration Pipeline and Clinical Trials Assessment 2023: FDA Approvals, Therapies and Key Companies involved by DelveInsight | Amgen, Roche, Adverum Biotechnologies, AsclepiX Therapeutics, Bioeq/Formycon, Sinocelltech, RemeGen, Alkah
"Age Related Macular Degeneration Pipeline Insight, 2023" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Age Related Macular Degeneration Market.
The Age Related Macular Degeneration Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.
Some of the key takeaways from the Age Related Macular Degeneration Pipeline Report: https://www.delveinsight.com/sample-request/age-related-macular-degeneration-amd-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
• Companies across the globe are diligently working toward developing novel Age Related Macular Degeneration treatment therapies with a considerable amount of success over the years.
• Age Related Macular Degeneration companies working in the treatment market are Avirmax Inc, Ripple Therapeutics, Innovent Biologics (Suzhou) Co. Ltd, ONL Therapeutics, Shanghai Biomabs Pharmaceutical Ltd., Innovent Biologics (Suzhou) Co. Ltd., Sylentis, S.A, UNITY Biotechnology, Metagone Biotech Inc., RemeGen Co., Ltd., Sam Chun Dang Pharm. Co. Ltd, Zhaoke Ophthalmology Pharmaceutical Ltd, Sinocelltech, and others, are developing therapies for the Age Related Macular Degeneration treatment
• Emerging Age Related Macular Degeneration therapies in the different phases of clinical trials are- ABI-210, ABI-220, RTC-1020, ABI-112, IBI-333, ONL-1204, CMAB818, IBI-302, SYL1801, UBX1325, MG-O-1002, RC28-E, SCD411, TAB014, SCT510A, and others are expected to have a significant impact on the Age Related Macular Degeneration market in the coming years.
• In March 2023, In order to compare the effectiveness and safety of RC28-E injection-a chimric decoy receptor trap fusion protein via dualblockage of VEGF and FGF-2-versus aflibercept in patients with wet age-related macular degeneration, RemeGen Co., Ltd. launched a randomized, double-masked, multicenter research.
• In June 2022, A Phase III, randomized, multicenter, double-blind clinical trial evaluating the efficacy and safety of TAB014 with Lucentis in patients with inneovascular age-related macular degeneration (nAMD) was started by Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. In this trial, patients with neovascular age-related macular degeneration underwent randomized, multi-center, double-blind, and Lucentis controlled non-inferiority testing.
• On March 9 2022, ZhaokeGuangzhou will have complete control and responsibility for the execution of clinical trials as well as the ultimate decision-making power in the development and commercialization of TAB014 in China, Hong Kong, and Macau, according to a supplemental agreement the Group entered into with TOT BIOPHARM. In addition to wAMD or innovative formulations for ocular diseases, Zhaoke Guangzhou is also permitted to develop TAB014 for other ophthalmic indications. TAB014 will continue to be manufactured by TOT BIOPHARM for both clinical trials and commercial uses.
• In December 2020, Hemera Biosciences sold Janssen Pharmaceuticals the rights to use HMR 59 to treat severe late-stage age-related macular degeneration (AMD).
Age Related Macular Degeneration Overview
A condition of the eyes called age-related macular degeneration (AMD) can cause central vision to become blurry. It occurs when the macula, the area of the eye that regulates precise, straight-ahead vision, suffers damage with age. The macula is a component of the retina, the tissue in the rear of the eye that is sensitive to light.
Get a Free Sample PDF Report to know more about Age Related Macular Degeneration Pipeline Therapeutic Assessment-
https://www.delveinsight.com/report-store/age-related-macular-degeneration-amd-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Emerging Age Related Macular Degeneration Drugs Under Different Phases of Clinical Development Include:
• ABI-210: Avirmax Inc
• ABI-220: Avirmax Inc
• RTC-1020: Ripple Therapeutics
• ABI-112: Avirmax Inc
• IBI-333: Innovent Biologics (Suzhou) Co. Ltd
• ONL-1204: ONL Therapeutics
• CMAB818: Shanghai Biomabs Pharmaceutical Ltd.
• IBI-302: Innovent Biologics (Suzhou) Co. Ltd.
• SYL1801: Sylentis, S.A
• UBX1325: UNITY Biotechnology
• MG-O-1002: Metagone Biotech Inc.
• RC28-E: RemeGen Co., Ltd.
• SCD411: Sam Chun Dang Pharm. Co. Ltd
• TAB014: Zhaoke Ophthalmology Pharmaceutical Ltd
• SCT510A: Sinocelltech
Age Related Macular Degeneration Pipeline Therapeutics Assessment
• Age Related Macular Degeneration Assessment by Product Type
• Age Related Macular Degeneration By Stage and Product Type
• Age Related Macular Degeneration Assessment by Route of Administration
• Age Related Macular Degeneration By Stage and Route of Administration
• Age Related Macular Degeneration Assessment by Molecule Type
• Age Related Macular Degeneration by Stage and Molecule Type
DelveInsight's Age Related Macular Degeneration Report covers around products under different phases of clinical development like
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
• Route of Administration
Further Age Related Macular Degeneration product details are provided in the report. Download the Age Related Macular Degeneration pipeline report to learn more about the emerging Age Related Macular Degeneration therapies at:
https://www.delveinsight.com/sample-request/age-related-macular-degeneration-amd-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the key companies in the Age Related Macular Degeneration Therapeutics Market include:
Key companies developing therapies for Age Related Macular Degeneration are - Amgen, Roche, Adverum Biotechnologies, AsclepiX Therapeutics, Bioeq/Formycon, Sinocelltech, RemeGen, Alkahest, Kyowa Kirin, Unity Biotechnology, Stealth BioTherapeutics, AiViva BioPharma, Ocular Therapeutix, AO GENERIUM, Gyroscope Therapeutics, EyePoint Pharmaceutical, IVERIC bio, Kodiak Sciences, Ribomic USA Inc, Sunshine Guojian Pharmaceutical (Shanghai), Lineage Cell Therapeutics, Graybug Vision, Sinocelltech, Luxa Biotechnology, CHABiotech, Shanghai Henlius Biotech, Bio-Thera Solutions, Alteogen, Samsung Bioepis, Outlook Therapeutics, Ionis Pharmaceuticals, Aerie Pharmaceuticals, Outlook Therapeutics, and several others.
Age Related Macular Degeneration Pipeline Analysis:
The Age Related Macular Degeneration pipeline report provides insights into
• The report provides detailed insights about companies that are developing therapies for the treatment of Age Related Macular Degeneration with aggregate therapies developed by each company for the same.
• It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Age Related Macular Degeneration Treatment.
• Age Related Macular Degeneration key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• Age Related Macular Degeneration Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Age Related Macular Degeneration market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.
Download Sample PDF Report to know more about Age Related Macular Degeneration drugs and therapies-
https://www.delveinsight.com/sample-request/age-related-macular-degeneration-amd-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Age Related Macular Degeneration Pipeline Market Drivers
• The Rise in the prevalence of Age Related Macular Degeneration (AMD), increasing Research and Developmental Activities are some of the important factors that are fueling the Age Related Macular Degeneration Market.
Age Related Macular Degeneration Pipeline Market Barriers
• However, poor in the quality of care, poor prognosis and lack of efficacy resulting in persistently active disease, morbidity Related to the Disease and other factors are creating obstacles in the Age Related Macular Degeneration Market growth.
Scope of Age Related Macular Degeneration Pipeline Drug Insight
• Coverage: Global
• Key Age Related Macular Degeneration Companies: Avirmax Inc, Ripple Therapeutics, Innovent Biologics (Suzhou) Co. Ltd, ONL Therapeutics, Shanghai Biomabs Pharmaceutical Ltd., Innovent Biologics (Suzhou) Co. Ltd., Sylentis, S.A, UNITY Biotechnology, Metagone Biotech Inc., RemeGen Co., Ltd., Sam Chun Dang Pharm. Co. Ltd, Zhaoke Ophthalmology Pharmaceutical Ltd, Sinocelltech, and others
• Key Age Related Macular Degeneration Therapies: ABI-210, ABI-220, RTC-1020, ABI-112, IBI-333, ONL-1204, CMAB818, IBI-302, SYL1801, UBX1325, MG-O-1002, RC28-E, SCD411, TAB014, SCT510A, and others
• Age Related Macular Degeneration Therapeutic Assessment: Age Related Macular Degeneration current marketed and Age Related Macular Degeneration emerging therapies
• Age Related Macular Degeneration Market Dynamics: Age Related Macular Degeneration market drivers and Age Related Macular Degeneration market barriers
Request for Sample PDF Report for Age Related Macular Degeneration Pipeline Assessment and clinical trials-
https://www.delveinsight.com/sample-request/age-related-macular-degeneration-amd-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Table of Contents
1. Age Related Macular Degeneration Report Introduction
2. Age Related Macular Degeneration Executive Summary
3. Age Related Macular Degeneration Overview
4. Age Related Macular Degeneration- Analytical Perspective In-depth Commercial Assessment
5. Age Related Macular Degeneration Pipeline Therapeutics
6. Age Related Macular Degeneration Late Stage Products (Phase II/III)
7. Age Related Macular Degeneration Mid Stage Products (Phase II)
8. Age Related Macular Degeneration Early Stage Products (Phase I)
9. Age Related Macular Degeneration Preclinical Stage Products
10. Age Related Macular Degeneration Therapeutics Assessment
11. Age Related Macular Degeneration Inactive Products
12. Company-University Collaborations (Licensing/Partnering) Analysis
13. Age Related Macular Degeneration Key Companies
14. Age Related Macular Degeneration Key Products
15. Age Related Macular Degeneration Unmet Needs
16 . Age Related Macular Degeneration Market Drivers and Barriers
17. Age Related Macular Degeneration Future Perspectives and Conclusion
18. Age Related Macular Degeneration Analyst Views
19. Appendix
20. About DelveInsight
Related Reports:
Age Related Macular Degeneration Market https://www.delveinsight.com/report-store/age-related-macular-degeneration-amd-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Age Related Macular Degeneration Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth understanding of the 7MM, historical and forecasted epidemiology as well as the 7MM market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom),
Age Related Macular Degeneration Epidemiology https://www.delveinsight.com/report-store/age-related-macular-degeneration-amd-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Age Related Macular Degeneration Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Cholangiocarcinoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Latest Reports:
Non-invasive Prenatal Testing Market https://www.delveinsight.com/report-store/non-invasive-prenatal-testing-market
Non-Invasive Prenatal Testing Market By Product Type (Instruments And Kits And Reagents), By Indication (Down Syndrome, Edwards Syndrome, Patau Syndrome, Turner Syndrome, And Others), By End-User (Hospitals, Diagnostic Labs, And Others), and by geography is expected to grow at a steady CAGR forecast till 2028 owing to the increasing prevalence of chromosomal disorders and the increasing demand for early and non-invasive fetal diagnosis across the globe.
Orthopedic Implants Market https://www.delveinsight.com/report-store/orthopedic-implants-market
Orthopedic Implants Market By Product Type (Hip Implants, Knee Implants, Spinal Implants, Foot And Ankle Implants, And Others), By End-User (Hospitals, Orthopedic Clinics, And Others ), by geography is estimated to register growth at a remarkable CAGR forecast during 2023-2028 owing to increasing prevalence of orthopedic diseases and rising demand for personalized orthopedic implants.
Analgesics Market
https://www.delveinsight.com/report-store/analgesics-market
Analgesics Market By Product Type (Opioid And Non-Opioid), By Application (Musculoskeletal, Surgical And Trauma, Cancer, And Others), By Drug Type (Prescription And Over-The-Counter (Otc)) By Distribution Channels (Hospital Pharmacy & Retail Pharmacy, And E-Commerce) by geography is estimated to register growth at a remarkable CAGR forecast during 2023-2028 owing to the increasing prevalence of orthopedic, cancer, and other chronic diseases and rising demand of analgesics for the treatment of mild to moderate pain.
Animal Nutrition Market
https://www.delveinsight.com/report-store/animal-nutrition-market
Animal Nutrition Market By Product Type (Amino Acids, Enzymes, Vitamins And Minerals, Medicated Feed Additives, Antioxidants, And Others), By Animal Type (Poultry, Ruminant, Pet Food, And Others), by geography is estimated to register growth at a remarkable CAGR forecast during 2023-2028 owing to rising awareness on animal health and nutrition and increasing industrialisation of livestock production.
Point of Care Diagnostics Market
https://www.delveinsight.com/report-store/point-of-care-diagnostics-market
Point of Care Diagnostics Market By Product Type (Instruments, Kits And Reagents), By Application (Blood Glucose Monitoring, Infectious Diseases, Cardio-Metabolic Diseases, Pregnancy & Fertility Testing, And Others), By End-User (Hospitals, Diagnostic Centers, Home Care Settings, And Others), and by geography is expected to grow at a steady CAGR forecast till 2028 owing to the increasing prevalence of infectious and other lifestyle based disorders such as diabetes and cardiovascular diseases and growing awareness on health.
Hyaluronic Acid Viscosupplementation Market
https://www.delveinsight.com/report-store/hyaluronic-acid-viscosupplementation-market
The Hyaluronic Acid Viscosupplementation Market By Treatment Type (Single Injection, Three Injections, And Five Injections), By End-User (Hospitals, Specialty Clinics, And Others), And By Geography Is Expected To Grow At A Steady CAGR forecast till 2028 owing to the increasing prevalence of osteoarthritis, particularly among the geriatric population and increasing demand for non-surgical treatment options for osteoarthritis.
Frozen Food Market
https://www.delveinsight.com/report-store/frozen-food-market
Frozen Foods Market By Product (Fruits & Vegetables, Dairy Products, Meat Products, Seafood Products, And Others), By Product Type (Raw Material, Half-Cooked And Ready-To-Eat), By Distribution Channel (Hypermarkets And Supermarkets, General Stores, E-Commerce, And Others), by geography is estimated to register growth at a remarkable CAGR forecast during 2023-2028 owing to rise in the demand for ready-to-eat dishes, overall increase in the average income of individuals, rising work culture in countries, lack of time, usage of foods for extended period and others, along with the rising advancements in delivering quality and preservative-free frozen foods across the globe.
Intrauterine Pressure Catheters Market
https://www.delveinsight.com/report-store/intrauterine-pressure-catheters-market
Intrauterine Pressure Catheters Market By Product (Fluid-Filled Catheters And Transducer Tip Catheters), By End-User (Hospitals, Ambulatory Surgical Centers (ASCS), And Specialty Clinics), and by geography is expected to advance at a respectable CAGR forecast till 2028 owing to the growing number complications in pregnancy and rising focus on maternal and fetal care across the globe.
Contact Us:
Gaurav Bora
gbora@delveinsight.com
+1(919)321-6187
Healthcare Consulting
https://www.delveinsight.com/consulting-services
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Age Related Macular Degeneration Pipeline and Clinical Trials Assessment 2023: FDA Approvals, Therapies and Key Companies involved by DelveInsight | Amgen, Roche, Adverum Biotechnologies, AsclepiX Therapeutics, Bioeq/Formycon, Sinocelltech, RemeGen, Alkah here
News-ID: 3260426 • Views: …
More Releases from DelveInsight Business Research
Niemann-Pick Type C Pipeline Report Showcases Emerging Drugs and Leading Compani …
DelveInsight's, "Niemann Pick C Disease Pipeline Insight, 2025" report provides comprehensive insights about 10+ companies and 15+ pipeline drugs in Niemann Pick C Disease pipeline landscape. It covers the Niemann-Pick Type C pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Niemann-Pick Type C pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this…
Pemphigus Vulgaris Market Positioned for Accelerated Development Through 2034, D …
DelveInsight's "Pemphigus Vulgaris Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Pemphigus Vulgaris, historical and forecasted epidemiology as well as the Pemphigus Vulgaris market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Pemphigus Vulgaris market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Pemphigus Vulgaris Market Forecast
https://www.delveinsight.com/sample-request/pemphigus-vulgaris-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the…
Osteogenesis Imperfecta Market to Evolve Rapidly Over the Next Decade by 2034, D …
The Osteogenesis Imperfecta market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Osteogenesis Imperfecta pipeline products will significantly revolutionize the Osteogenesis Imperfecta market dynamics.
DelveInsight's "Osteogenesis Imperfecta Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Osteogenesis Imperfecta, historical and forecasted epidemiology as well as the Osteogenesis Imperfecta market trends in the United…
Myopic Macular Degeneration Market Insights Highlight Expanding Outlook Till 203 …
DelveInsight's "Myopic Macular Degeneration Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Myopic Macular Degeneration, historical and forecasted epidemiology as well as the Myopic Macular Degeneration market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
The latest healthcare forecast report provides an in-depth analysis of Myopic Macular Degeneration, offering comprehensive insights into the Myopic Macular Degeneration revenue trends,…
More Releases for Age
Easy Age Calculator Introduces Tree Age Calculator for Nature Insights
Trees are often called the "silent witnesses of history." They stand tall for decades, centuries, and sometimes even thousands of years, quietly recording changes in climate, culture, and environment. Today, Easy Age Calculator, a trusted online hub for age-related tools, has launched its Tree Age Calculator, an innovative digital tool that allows people to estimate the age of trees in a safe, accessible, and accurate way.
This launch reflects the company's…
Dark Age Defense Survival Guide
Get Dark Age Defense For A Very Special Price >> https://rebrand.ly/2f043b
People should know how to keep themselves and their families safe, especially in times like this where there is a high probability of natural disasters, power blackouts, wars, and other severe conditions.
The Dark Age Defense is a digital survival aid that provides users with detailed information on various topics including how to create electricity and keep your household appliances…
Adult Milk Powder Market Introducing New Industry Dynamics Through Swot Analysis …
LOS ANGELES, UNITED STATES - The report comes out as an intelligent and thorough assessment tool as well as a great resource that will help you to secure a position of strength in the global Adult Milk Powder market. It includes Porter’s Five Forces and PESTLE analysis to equip your business with critical information and comparative data about the Global Adult Milk Powder Market. We have provided deep analysis of…
Tattoo Ink Market Size, By Type (Black & Grey Tattoo Ink, Colour Tattoo Ink), By …
Global demand for tattoo ink market was valued at approximately USD 80 million in 2018 and is expected to generate revenue of around USD 142 million by end of 2025, growing at a CAGR of around 5.7% between 2019 and 2025.
A recent market research report added to repository of Credible Markets is an in-depth analysis of Global Tattoo Ink Market. On the basis of historic growth analysis and current…
Age Discrimination
Age Discrimination looks at how both young and old can be penalised by prejudice against their age group. This comprehensive new book is essential to practitioners responsible for HR issues, finance, operations, service delivery, quality and customer relations, and for those with a policy focus or academic interest in diversity issues.
Gower is recognised as one of the world's leading publishers of specialist business and management books and resources. Our publishing…
Victorian Age Meets Digital Age
The digital age is entering the elegant Victorian age Eurocentres school building. In some classrooms interactive whiteboards have been installed and are now being intensively used with language students from all over the world.
The interactive whiteboards have been helping classes become much more exciting and closer to real life. This user-friendly technology enables students to better engage with and discuss up-to-date news or life-style features, enjoy playful grammar exercises,…
